206 related articles for article (PubMed ID: 1709860)
1. The nitric oxide synthase II inhibitor NG-nitro-L-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas.
Jansson L; Sandler S
Endocrinology; 1991 Jun; 128(6):3081-5. PubMed ID: 1709860
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats.
Svensson AM; Ostenson CG; Sandler S; Efendic S; Jansson L
Endocrinology; 1994 Sep; 135(3):849-53. PubMed ID: 7520863
[TBL] [Abstract][Full Text] [Related]
4. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
Laychock SG; Modica ME; Cavanaugh CT
Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
[TBL] [Abstract][Full Text] [Related]
5. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
Panagiotidis G; Akesson B; Rydell EL; Lundquist I
Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of islet nitric oxide synthase increases arginine-induced insulin release.
Panagiotidis G; Alm P; Lundquist I
Eur J Pharmacol; 1992 Dec; 229(2-3):277-8. PubMed ID: 1283375
[TBL] [Abstract][Full Text] [Related]
7. Islet constitutive nitric oxide synthase: biochemical determination and regulatory function.
Salehi A; Carlberg M; Henningson R; Lundquist I
Am J Physiol; 1996 Jun; 270(6 Pt 1):C1634-41. PubMed ID: 8764145
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion.
Gross R; Roye M; Manteghetti M; Broca C; Hillaire-Buys D; Masiello P; Ribes G
Br J Pharmacol; 1997 Feb; 120(3):495-501. PubMed ID: 9031755
[TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
12. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production.
Henningsson R; Lundquist I
Am J Physiol; 1998 Sep; 275(3):E500-6. PubMed ID: 9725818
[TBL] [Abstract][Full Text] [Related]
13. The blood flow in pancreatico-duodenal grafts in rats: inhibition of nitric oxide synthase preferentially decreases islet blood flow.
Svensson AM; Sandler S; Jansson L
Eur J Pharmacol; 1995 Feb; 275(1):99-103. PubMed ID: 7539767
[TBL] [Abstract][Full Text] [Related]
14. Does nitric oxide play a role in stimulus-secretion and/or synthesis-secretion coupling of insulin?
Strandgaard C; Curry DL
Pancreas; 1999 Aug; 19(2):175-82. PubMed ID: 10438165
[TBL] [Abstract][Full Text] [Related]
15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion.
Bilski J; Konturek SJ; Bielański W
J Physiol Pharmacol; 1995 Dec; 46(4):447-62. PubMed ID: 8770789
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide regulates insulin secretion in the isolated perfused human pancreas via a cholinergic mechanism.
Atiya A; Cohen G; Ignarro L; Brunicardi FC
Surgery; 1996 Aug; 120(2):322-7. PubMed ID: 8751600
[TBL] [Abstract][Full Text] [Related]
18. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production.
Mosén H; Ostenson CG; Lundquist I; Alm P; Henningsson R; Jimenez-Feltström J; Guenifi A; Efendic S; Salehi A
Regul Pept; 2008 Nov; 151(1-3):139-46. PubMed ID: 18662725
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release.
Henningsson R; Salehi A; Lundquist I
Am J Physiol Cell Physiol; 2002 Jul; 283(1):C296-304. PubMed ID: 12055099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]